Screening of drugs for activity against Mycobacterium leprae.
Baohong
J
J
Leprosy Unit, World Health Organization, Geneva, Switzerland.
Matsuo
Y
Y
Colston
M J
MJ
D000818:Animals; D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical / Q000379:methods; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000188:drug therapy*; D051379:Mice; D009166:Mycobacterium leprae / Q000187:drug effects* / Q000302:isolation & purification; D012293:Rifampin / Q000627:therapeutic use; D013854:Thioamides / Q000627:therapeutic use
D007917:Leprostatic Agents; D013854:Thioamides; D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin